TAVI, Renal Denervation in Meeting Spotlight

ACC 2014 — WASHINGTON, DC — Standing above the rest of the trials at the upcoming American College of Cardiology meeting here will be two in particular — SYMPLICITY HTN-3 and the CoreValve U.S. Pivotal Trial high-risk cohort. Read More >>>

Keywords: ACC Annual Scientific Session


< Back to Listings